Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Le Roux

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Immunology|May 22, 2018
Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage ImbalancesAnna Ohradanova-Repic, Christian Machacek, Celine Charvet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 29, 2025
Systematic review and modelling of <i>Toxoplasma gondii</i> seroprevalence in humans, Europe, 2000 to 2021Ingrid Hm Friesema, Helga Waap, Arno Swart, et al.
JNCI Cancer Spectrum|December 14, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)Florence Joly, Fernando Bazan, Delphine Garbay, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Immunology|May 22, 2018
Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage ImbalancesAnna Ohradanova-Repic, Christian Machacek, Celine Charvet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 29, 2025
Systematic review and modelling of <i>Toxoplasma gondii</i> seroprevalence in humans, Europe, 2000 to 2021Ingrid Hm Friesema, Helga Waap, Arno Swart, et al.
JNCI Cancer Spectrum|December 14, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)Florence Joly, Fernando Bazan, Delphine Garbay, et al.
Pageof 4